Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Research article

Assessing agreement between the three common clinical measurement methods of HbA1c

Authors: Mohammad Taha Jalali, Samaneh Salehipour Bavarsad, Saeed Hesam, Mohammad Reza Afsharmanesh, Narges Mohammadtaghvaei

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Reliable measurement of hemoglobin A1c (HbA1c) has great importance in the diagnosis and monitoring of diabetes mellitus. The aim of the present study was to compare the performance parameters of the three common methods of HbA1c assay, including the Roche, Sebia and TOSOH G8 systems. We studied 120 patients referred to a clinical laboratory for HbA1c assay. The blood samples were analyzed with the Roche, Sebia and TOSOH G8 systems based on immunoassay, capillary electrophoresis, and ion-exchange chromatography techniques, respectively. The Spearman and the Passing-Bablok regression,as well as the Bland-Altman plots, were used to compare these methods. For each assay, the patients’ classification was evaluated at the three cut-points of 6.5, 7, and 8% and the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the methods were estimated. Our results showed that there were good correlations and agreement between the methods. We found a mean difference of 0.07% for the TOSOH G8 vs. Roche, 0.06% for the TOSOH G8 vs. Sebia and − 0.01% for the Roche vs. Sebia. The methods represented very low bias, indicating the good accuracy of the results. The sensitivity and specificity of the methods were comparable as well. The three methods also performed similarly in the classification of patients at the proposed cut-off points. Based on our results, the Roche, Sebia and TOSOH G8 systems showed a very high level of agreement with comparable performance parameters and yielded similar and accurate classification of diabetic patients. Therefore, these methods can be used interchangeably.
Literature
1.
go back to reference Tesija Kuna A, Dukic K, Nikolac Gabaj N, et al. Comparison of enzymatic assay for HbA1c measurement (Abbott Architect) with capillary electrophoresis (Sebia Minicap Flex piercing analyser). Lab Med. 2018;49(3):231–8.PubMed Tesija Kuna A, Dukic K, Nikolac Gabaj N, et al. Comparison of enzymatic assay for HbA1c measurement (Abbott Architect) with capillary electrophoresis (Sebia Minicap Flex piercing analyser). Lab Med. 2018;49(3):231–8.PubMed
2.
go back to reference Klingenberg O, Furuset T, Hestbråten CR, Hallberg MH, Steiro A, Orset IR, et al. HbA1c analysis by capillary electrophoresis–comparison with chromatography and an immunological method. Scand J Clin Lab Invest. 2017;77(6):458–64.CrossRef Klingenberg O, Furuset T, Hestbråten CR, Hallberg MH, Steiro A, Orset IR, et al. HbA1c analysis by capillary electrophoresis–comparison with chromatography and an immunological method. Scand J Clin Lab Invest. 2017;77(6):458–64.CrossRef
3.
go back to reference Wu X, Chao Y, Wan Z, Wang Y, Ma Y, Ke P, et al. A comparative evaluation of the analytical performances of Capillarys 2 flex piercing, Tosoh HLC-723 G8, premier Hb9210, and Roche Cobas c501 Tina-quant gen 2 analyzers for HbA1c determination. Biochemia medica: Biochem Medica. 2016;26(3):353–64.CrossRef Wu X, Chao Y, Wan Z, Wang Y, Ma Y, Ke P, et al. A comparative evaluation of the analytical performances of Capillarys 2 flex piercing, Tosoh HLC-723 G8, premier Hb9210, and Roche Cobas c501 Tina-quant gen 2 analyzers for HbA1c determination. Biochemia medica: Biochem Medica. 2016;26(3):353–64.CrossRef
4.
go back to reference Rollborn N, Åkerfeldt T, Nordin G, Xu XY, Mandic-Havelka A, Hansson LO, et al. Analysis of HbA1c on an automated multicapillary zone electrophoresis system. Scand J Clin Lab Invest. 2017;77(1):15–8.CrossRef Rollborn N, Åkerfeldt T, Nordin G, Xu XY, Mandic-Havelka A, Hansson LO, et al. Analysis of HbA1c on an automated multicapillary zone electrophoresis system. Scand J Clin Lab Invest. 2017;77(1):15–8.CrossRef
5.
go back to reference Jaisson S, Leroy N, Meurice J, Guillard E, Gillery P. First evaluation of Capillarys 2 flex piercing®(Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis. Clin Chem Lab Med. 2012;50(10):1769–75.CrossRef Jaisson S, Leroy N, Meurice J, Guillard E, Gillery P. First evaluation of Capillarys 2 flex piercing®(Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis. Clin Chem Lab Med. 2012;50(10):1769–75.CrossRef
6.
go back to reference Association AD. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Supplement 1):S14–80.CrossRef Association AD. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Supplement 1):S14–80.CrossRef
7.
go back to reference Razi F, Esfahani EN, Farzami MR, et al. Effect of the different assays of HbA1c on diabetic patients monitoring. J Diabetes Metab Disord. 2015;14(1):65. Razi F, Esfahani EN, Farzami MR, et al. Effect of the different assays of HbA1c on diabetic patients monitoring. J Diabetes Metab Disord. 2015;14(1):65.
8.
go back to reference Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline. 2nd ed, document EP05-A2. Wayne: CLSI;2004. Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline. 2nd ed, document EP05-A2. Wayne: CLSI;2004.
9.
go back to reference Heylen O, Van Neyghem S, Exterbille S, et al. Evaluation of the Sebia CAPILLARYS 2 flex piercing for the measurement of HbA1c on venous and capillary blood samples. Am J Clin Pathol. 2014;141(6):867–77.CrossRef Heylen O, Van Neyghem S, Exterbille S, et al. Evaluation of the Sebia CAPILLARYS 2 flex piercing for the measurement of HbA1c on venous and capillary blood samples. Am J Clin Pathol. 2014;141(6):867–77.CrossRef
10.
go back to reference Genc S, Gurdol F, Kanmaz-Ozer M, et al. The analytical performances of four different glycated hemoglobin methods. Med Chem. 2014;4(501):5. Genc S, Gurdol F, Kanmaz-Ozer M, et al. The analytical performances of four different glycated hemoglobin methods. Med Chem. 2014;4(501):5.
11.
go back to reference Hanita O, Hanisah AH, Subashini CT, et al. The performance evaluation of Tina-Quant Roche Cobas 6000 in the measurement of HbA1c. Pathology. 2009;41:69. Hanita O, Hanisah AH, Subashini CT, et al. The performance evaluation of Tina-Quant Roche Cobas 6000 in the measurement of HbA1c. Pathology. 2009;41:69.
12.
go back to reference Dessi M, Pieri M, Pignalosa S, Martino FG, Zenobi R. Performances of capillary electrophoresis and HPLC methods in HbA1c determination: diagnostic accuracy in HbS and HbD-Iran variants' presence. J Clin Lab Anal. 2015;29(1):57–60.CrossRef Dessi M, Pieri M, Pignalosa S, Martino FG, Zenobi R. Performances of capillary electrophoresis and HPLC methods in HbA1c determination: diagnostic accuracy in HbS and HbD-Iran variants' presence. J Clin Lab Anal. 2015;29(1):57–60.CrossRef
13.
go back to reference Rohlfing CL, Connolly SM, England JD, Hanson SE, Moellering CM, Bachelder JR, et al. The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 2008;129(5):811–4.CrossRef Rohlfing CL, Connolly SM, England JD, Hanson SE, Moellering CM, Bachelder JR, et al. The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 2008;129(5):811–4.CrossRef
14.
go back to reference Aksungar FB, Serteser M, Coşkun A, Ünsal İ. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement. Clin Chem Lab Med. 2013;51(8):e191–3.CrossRef Aksungar FB, Serteser M, Coşkun A, Ünsal İ. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement. Clin Chem Lab Med. 2013;51(8):e191–3.CrossRef
Metadata
Title
Assessing agreement between the three common clinical measurement methods of HbA1c
Authors
Mohammad Taha Jalali
Samaneh Salehipour Bavarsad
Saeed Hesam
Mohammad Reza Afsharmanesh
Narges Mohammadtaghvaei
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00503-6

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine